Literature DB >> 18216183

Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP.

Cheryl D Cropp1, Takafumi Komori, James E Shima, Thomas J Urban, Sook Wah Yee, Swati S More, Kathleen M Giacomini.   

Abstract

The second messenger, cGMP, mediates a host of cellular responses to various stimuli, resulting in the regulation of many critical physiologic functions. The existence of specific cGMP transporters on the plasma membrane that participate in the regulation of cGMP levels has been suggested in a large number of studies. In this study, we identified a novel plasma membrane transporter for cGMP. In particular, we showed that hOAT2 (SLC22A7), a member of the solute carrier (SLC) superfamily, was a facilitative transporter for cGMP and other guanine nucleotides. hOAT2, which is ubiquitously expressed at high levels in many cell types, was previously thought to primarily transport organic anions. Among purine and pyrimidine nucleobases, nucleosides, and nucleotides, hOAT2 showed the greatest preference for cGMP, which transported cGMP with a K(m) value of 88 +/- 11 muM and exhibited between 50- and 100-fold enhanced uptake over control cells. Our data revealed that hOAT2 is a bidirectional facilitative transporter that can control both intracellular and extracellular levels of cGMP. In addition, we observed that a common alternatively spliced variant of hOAT2 demonstrated a complete loss of transport function as a result of a low expression level on the plasma membrane. We conclude that hOAT2 is a highly efficient, facilitative transporter of cGMP and may be involved in cGMP signaling in many tissues. Our study suggests that hOAT2 represents a potential new drug target for regulating cGMP levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216183      PMCID: PMC2698938          DOI: 10.1124/mol.107.043117

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  27 in total

1.  Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine.

Authors:  Z S Chen; K Lee; G D Kruh
Journal:  J Biol Chem       Date:  2001-07-10       Impact factor: 5.157

Review 2.  Regulation of nitric oxide-sensitive guanylyl cyclase.

Authors:  Andreas Friebe; Doris Koesling
Journal:  Circ Res       Date:  2003-07-25       Impact factor: 17.367

3.  Isolation of a family of organic anion transporters from human liver and kidney.

Authors:  W Sun; R R Wu; P D van Poelje; M D Erion
Journal:  Biochem Biophys Res Commun       Date:  2001-05-04       Impact factor: 3.575

4.  Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.

Authors:  S H Cha; T Sekine; J I Fukushima ; Y Kanai; Y Kobayashi; T Goya; H Endou
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

5.  Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).

Authors:  Thomas J Urban; Renata C Gallagher; Chaline Brown; Richard A Castro; Leah L Lagpacan; Claire M Brett; Travis R Taylor; Elaine J Carlson; Thomas E Ferrin; Esteban G Burchard; Seymour Packman; Kathleen M Giacomini
Journal:  Mol Pharmacol       Date:  2006-08-24       Impact factor: 4.436

6.  The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides.

Authors:  G Jedlitschky; B Burchell; D Keppler
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

7.  Role of cyclic GMP in glutamate neurotoxicity in primary cultures of cerebellar neurons.

Authors:  C Montoliu; M Llansola; E Kosenko; R Corbalán; V Felipo
Journal:  Neuropharmacology       Date:  1999-12       Impact factor: 5.250

Review 8.  Transport of organic anions across the basolateral membrane of proximal tubule cells.

Authors:  B C Burckhardt; G Burckhardt
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-01-30       Impact factor: 5.545

Review 9.  The equilibrative nucleoside transporter family, SLC29.

Authors:  Stephen A Baldwin; Paul R Beal; Sylvia Y M Yao; Anne E King; Carol E Cass; James D Young
Journal:  Pflugers Arch       Date:  2003-06-28       Impact factor: 3.657

10.  MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine.

Authors:  Yanping Guo; Elena Kotova; Zhe-Sheng Chen; Kun Lee; Elizabeth Hopper-Borge; Martin G Belinsky; Gary D Kruh
Journal:  J Biol Chem       Date:  2003-05-22       Impact factor: 5.157

View more
  36 in total

1.  A genome-wide association study of bronchodilator response in Latinos implicates rare variants.

Authors:  Katherine A Drake; Dara G Torgerson; Christopher R Gignoux; Joshua M Galanter; Lindsey A Roth; Scott Huntsman; Celeste Eng; Sam S Oh; Sook Wah Yee; Lawrence Lin; Carlos D Bustamante; Andrés Moreno-Estrada; Karla Sandoval; Adam Davis; Luisa N Borrell; Harold J Farber; Rajesh Kumar; Pedro C Avila; Emerita Brigino-Buenaventura; Rocio Chapela; Jean G Ford; Michael A Lenoir; Fred Lurmann; Kelley Meade; Denise Serebrisky; Shannon Thyne; William Rodríguez-Cintrón; Saunak Sen; José R Rodríguez-Santana; Ryan D Hernandez; Kathleen M Giacomini; Esteban G Burchard
Journal:  J Allergy Clin Immunol       Date:  2013-08-29       Impact factor: 10.793

Review 2.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

Review 3.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

4.  Is cIMP a second messenger with functions opposite to those of cGMP?

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-15       Impact factor: 3.000

Review 5.  Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.

Authors:  Maciej J Zamek-Gliszczynski; Mitchell E Taub; Paresh P Chothe; Xiaoyan Chu; Kathleen M Giacomini; Richard B Kim; Adrian S Ray; Sophie L Stocker; Jashvant D Unadkat; Matthias B Wittwer; Cindy Xia; Sook-Wah Yee; Lei Zhang; Yan Zhang
Journal:  Clin Pharmacol Ther       Date:  2018-08-08       Impact factor: 6.875

Review 6.  Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.

Authors:  Wooin Lee; Jeong-Min Ha; Yuichi Sugiyama
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

Review 7.  Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.

Authors:  Ji Eun Park; Gongmi Ryoo; Wooin Lee
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

8.  Functional characterization of liver enhancers that regulate drug-associated transporters.

Authors:  M J Kim; P Skewes-Cox; H Fukushima; S Hesselson; S W Yee; L B Ramsey; L Nguyen; J L Eshragh; R A Castro; C C Wen; D Stryke; S J Johns; T E Ferrin; P-Y Kwok; M V Relling; K M Giacomini; D L Kroetz; N Ahituv
Journal:  Clin Pharmacol Ther       Date:  2011-03-02       Impact factor: 6.875

9.  Dependence of multidrug resistance protein-mediated cyclic nucleotide efflux on the background sodium conductance.

Authors:  Marek Kucka; Karla Kretschmannova; Takayo Murano; Chung-Pu Wu; Hana Zemkova; Suresh V Ambudkar; Stanko S Stojilkovic
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

Review 10.  Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.

Authors:  Sun-Young Ahn; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2009-06-10       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.